Skip to content

Epidemiological, Clinical, Microbiological and Outcome Description of Patients With Klebsiella sp Meningitis

Epidemiological, Clinical, Microbiological and Outcome Description of Patients With Klebsiella sp Meningitis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03967210
Acronym
KlebsieLCR
Enrollment
132
Registered
2019-05-30
Start date
2019-07-05
Completion date
2020-01-13
Last updated
2021-08-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Meningitis

Brief summary

Klebsiella pneumoniae is implicated in the occurrence of severe pneumonia. Most Klebsiella pneumoniae infections are associated with care and occur in patients with compromised immune defenses. More recently, cases of hepatic abscess and acute community meningitis related to strains of Klebsiella pneumoniae have been reported. The mortality of these infections is important, most often due to a delayed diagnosis. The poor prognostic factors reported in the literature for very low numbers are: advanced age, coma, septic shock, glyceryachia \<10mg / dL and proteinuria\> 750 mg / dL. In addition, no study has specifically focused on the factors of occurrence and factors associated with Klebsiella sp. Indeed, meningitis related to Klebsiella pneumoniae seems to be a rare but probably underestimated event whose risk factors, clinical presentation, microbiological are little known and the treatment modalities of this severe infection are not codified.

Interventions

None listed

Sponsors

Fondation Hôpital Saint-Joseph
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Man or Woman whose age ≥ 18 years * Patient with meningitis Klebsiella sp., hospitalized in one of the hospitals of the Clinical Microbiology Group * Francophone patient

Exclusion criteria

* Patient under tutorship or curatorship * Patient deprived of liberty * Patient under safeguard of justice * Patient opposing his participation

Design outcomes

Primary

MeasureTime frameDescription
Characterize meningitis with Klebsiella pneumoniaeDay 1This corresponds to characterize Klebsiella pneumoniae meningitis, portal entry, secondary infection, associated antibiotic and associated therapies and the clinical course of patients.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026